Who
Justin J. Noznesky
Chief Mktg & Strategy Officer
Company insider
Files Form 4 as: Chief Mktg & Strategy Officer, AtriCure.
In numbers
- Trades disclosed
- 71
- Buys
- 0
- Sells
- 18
- Bought
- $0
- Sold
- $7.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Mar 2016
- Last trade
- 29 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jul 2026filed 30 Jul 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $240K6,182 at $38.80 | filing |
| 29 Jul 2026filed 30 Jul 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $240K6,182 at $38.80 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —27,991 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —15,198 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code F | $487K15,586 at $31.26 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —27,991 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —15,198 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code F | $487K15,586 at $31.26 | filing |
| 26 Nov 2025filed 26 Nov 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $193K5,166 at $37.29 | filing |
| 12 Sep 2025filed 16 Sep 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $109K3,000 at $36.30 | filing |
| 1 Mar 2025filed 4 Mar 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —19,359 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —6,579 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Code F | $375K9,673 at $38.74 | filing |
| 11 Dec 2024filed 12 Dec 2024 | ATRC AtriCureMedical Devices | SEC FORM 4 Code G | —585 at $0.00 | filing |
| 1 May 2024filed 3 May 2024 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $36K1,500 at $24.09 | filing |
| 1 Apr 2024filed 3 Apr 2024 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $46K1,500 at $30.39 | filing |
| 12 Mar 2024filed 14 Mar 2024 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $55K1,500 at $36.72 | filing |
| 1 Mar 2024filed 5 Mar 2024 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —19,294 at $0.00 | filing |
| 1 Mar 2024filed 5 Mar 2024 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —9,328 at $0.00 | filing |
| 1 Mar 2024filed 5 Mar 2024 | ATRC AtriCureMedical Devices | SEC FORM 4 Code F | $321K8,856 at $36.28 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Justin J. Noznesky; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.